1-4 of 4
Kinjal Sanghavi
Close
Sort by
Journal Articles

Population Pharmacokinetics of Subcutaneous Epcoritamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Tommy Li, Leonid Gibiansky, Apurvasena Parikh, Marcel van der Linden, Kinjal Sanghavi, Matthew Putnins, Mariana Sacchi, Huaibao Feng, Tahamtan Ahmadi, Manish Gupta, Steven Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4481.
https://doi.org/10.1182/blood-2023-179555
Published: 2023
Journal Articles

Phosphoramide Mustard (PM) Population Pharmacokinetics to Estimate Inter-Individual Variability in Exposure and Identify Clinical Factors Associated with Variability in Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HCT) Patients

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Mark Kirstein, PharmD, Richard Brundage, PharmD PhD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 2478.
https://doi.org/10.1182/blood.V124.21.2478.2478
Published: 2014
Journal Articles

Association of Cyclophosphamide (CY) and Fludarabine (FLU) Pharmacokinetics with Treatment Related Mortality (TRM) after Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT)

Anthony C. Wiseman, MD, Kinjal Sanghavi, M Pharm, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 1153.
https://doi.org/10.1182/blood.V124.21.1153.1153
Published: 2014
Journal Articles

Pharmacokinetic Modeling of Fludarabine to Control Exposure and Improve Outcomes after Reduced Intensity Conditioning Transplantation

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, Richard Brundage, PharmD PhD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 3869.
https://doi.org/10.1182/blood.V124.21.3869.3869
Published: 2014